These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 15388077)
21. TNF-alpha is crucial for the development of mast cell-dependent colitis in mice. Rijnierse A; Koster AS; Nijkamp FP; Kraneveld AD Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G969-76. PubMed ID: 16798721 [TBL] [Abstract][Full Text] [Related]
22. Persistent TNF-alpha exposure impairs store operated calcium influx in CD4+ T lymphocytes. Church LD; Goodall JE; Rider DA; Bacon PA; Young SP FEBS Lett; 2005 Feb; 579(6):1539-44. PubMed ID: 15733870 [TBL] [Abstract][Full Text] [Related]
23. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis. Sonoda KH; Yoshimura T; Takeda A; Ishibashi T; Hamano S; Yoshida H Int Immunol; 2007 Jan; 19(1):93-8. PubMed ID: 17118967 [TBL] [Abstract][Full Text] [Related]
24. Microarray analysis of cytokine and chemokine gene expression after prednisolone treatment in murine experimental autoimmune uveoretinitis. Hashida N; Ohguro N; Nakai K; Kobashi-Hashida M; Hashimoto S; Matsushima K; Tano Y Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4224-34. PubMed ID: 16249502 [TBL] [Abstract][Full Text] [Related]
25. Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis. de Kozak Y; Andrieux K; Villarroya H; Klein C; Thillaye-Goldenberg B; Naud MC; Garcia E; Couvreur P Eur J Immunol; 2004 Dec; 34(12):3702-12. PubMed ID: 15517615 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis. Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053 [TBL] [Abstract][Full Text] [Related]
27. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359 [TBL] [Abstract][Full Text] [Related]
29. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975 [TBL] [Abstract][Full Text] [Related]
30. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Kodama S; Davis M; Faustman DL Cell Mol Life Sci; 2005 Aug; 62(16):1850-62. PubMed ID: 15968469 [TBL] [Abstract][Full Text] [Related]
31. TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx. Church LD; Hessler G; Goodall JE; Rider DA; Workman CJ; Vignali DA; Bacon PA; Gulbins E; Young SP J Leukoc Biol; 2005 Jul; 78(1):266-78. PubMed ID: 15817701 [TBL] [Abstract][Full Text] [Related]
32. 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. Choi BK; Asai T; Vinay DS; Kim YH; Kwon BS Cytokine; 2006 Jun; 34(5-6):233-42. PubMed ID: 16899371 [TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways. Ho AW; Wong CK; Lam CW Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701 [TBL] [Abstract][Full Text] [Related]
34. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors. Aeberli D; Seitz M; Jüni P; Villiger PM Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629 [TBL] [Abstract][Full Text] [Related]
35. The role of soluble TNF receptors for TNF-alpha in uveitis. Sugita S; Takase H; Taguchi C; Mochizuki M Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3246-52. PubMed ID: 17591895 [TBL] [Abstract][Full Text] [Related]
36. The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Larmonier N; Cathelin D; Larmonier C; Nicolas A; Merino D; Janikashvili N; Audia S; Bateman A; Thompson J; Kottke T; Hartung T; Katsanis E; Vile R; Bonnotte B Exp Cell Res; 2007 Jul; 313(11):2345-55. PubMed ID: 17466973 [TBL] [Abstract][Full Text] [Related]
37. Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models. Kruglov AA; Kuchmiy A; Grivennikov SI; Tumanov AV; Kuprash DV; Nedospasov SA Cytokine Growth Factor Rev; 2008; 19(3-4):231-44. PubMed ID: 18502680 [TBL] [Abstract][Full Text] [Related]
38. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation. Wang YS; Chi KH; Chu RM Vet Immunol Immunopathol; 2007 Aug; 118(3-4):186-98. PubMed ID: 17617471 [TBL] [Abstract][Full Text] [Related]